— Know what they know.
Not Investment Advice

DXCM NASDAQ

DexCom, Inc.
1W: +24.4% 1M: +13.4% 3M: -1.6% YTD: +8.1% 1Y: -17.7% 3Y: -39.4% 5Y: -13.7%
$72.10
+0.20 (+0.28%)
 
Weekly Expected Move ±6.1%
$54 $58 $62 $65 $69
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 74 · $27.8B mcap · 384M float · 1.26% daily turnover · Short 46% of daily vol

Cash Flow Trends

Operating Cash Flow
$1.4B +45.6% ▲
5Y CAGR: +24.8%
Capital Expenditures
$364M -1.3% ▼
5Y CAGR: +12.8%
Free Cash Flow
$1.1B +70.8% ▲
5Y CAGR: +31.2%
Dividends Paid
$0 +0.0% ▲
Buybacks
$500M +33.3% ▲
Net Change in Cash
$312M +683.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$155M$341M$542M$576M$836M
Depreciation & Amort.$102M$156M$186M$218M$252M
Stock-Based Comp.$113M$126M$151M$170M$160M
Change in Working Capital-$132M$28M$3M$109M$103M
Other Non-Cash Items$209M$40M-$78M-$40M-$93M
Operating Cash Flow$442M$670M$748M$990M$1.4B
— Investing Activities —
Capital Expenditures-$389M-$365M-$237M-$359M-$364M
Acquisitions (Net)-$30M-$4M$0$0$0
Investment Purchases-$2.5B-$2.3B-$3.2B-$2.7B-$1.3B
Investment Sales$2.7B$2.1B$2.9B$2.8B$2.2B
Other Investing$10M-$14M-$18M-$16M$600K
Investing Cash Flow-$216M-$522M-$507M-$208M$536M
— Financing Activities —
Net Debt Issuance$0$0$443M$0-$1.2B
Stock Repurchased$0-$558M-$689M-$750M-$500M
Dividends Paid$0$0$0$0$0
Other Financing-$10M-$17M-$100M-$13M-$7M
Financing Cash Flow$10M-$552M-$319M-$735M-$1.7B
Net Change in Cash$235M-$410M-$76M$40M$312M
Cash End of Period$1.1B$643M$568M$607M$919M
Free Cash Flow$53M$305M$512M$631M$1.1B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms